Literature DB >> 24218313

Multiple Sclerosis International Federation: stimulating international cooperation in research.

Alan J Thompson1, Dhia Chandraratna.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24218313      PMCID： PMC3821717          DOI： 10.1212/01.wnl.0000435552.67953.c8

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

1.  Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis.

Authors:  T Chitnis; S Tenembaum; B Banwell; L Krupp; D Pohl; K Rostasy; E A Yeh; O Bykova; E Wassmer; M Tardieu; A Kornberg; A Ghezzi
Journal:  Mult Scler       Date:  2011-12-06       Impact factor: 6.312

2.  The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.

Authors:  Mark S Freedman; Amit Bar-Or; Harold L Atkins; Dimitrios Karussis; Francesco Frassoni; Hillard Lazarus; Neil Scolding; Shimon Slavin; Katarina Le Blanc; Antonio Uccelli
Journal:  Mult Scler       Date:  2010-01-19       Impact factor: 6.312

Review 3.  Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS.

Authors:  Robert J Fox; Alan Thompson; David Baker; Peer Baneke; Doug Brown; Paul Browne; Dhia Chandraratna; Olga Ciccarelli; Timothy Coetzee; Giancarlo Comi; Anthony Feinstein; Raj Kapoor; Karen Lee; Marco Salvetti; Kersten Sharrock; Ahmed Toosy; Paola Zaratin; Kim Zuidwijk
Journal:  Mult Scler       Date:  2012-08-23       Impact factor: 6.312
  3 in total
  1 in total

Review 1.  Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress.

Authors:  Xiaomo Wu; Ju Jiang; Zhongkai Gu; Jinyan Zhang; Yang Chen; Xiaolong Liu
Journal:  Stem Cell Res Ther       Date:  2020-08-08       Impact factor: 6.832
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.